Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measles.
Hübschen JM, Gouandjika-Vasilache I, Dina J. Hübschen JM, et al. Among authors: dina j. Lancet. 2022 Feb 12;399(10325):678-690. doi: 10.1016/S0140-6736(21)02004-3. Epub 2022 Jan 28. Lancet. 2022. PMID: 35093206 Review.
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Alizon S, Selinger C, Sofonea MT, Haim-Boukobza S, Giannoli JM, Ninove L, Pillet S, Thibault V, de Rougemont A, Tumiotto C, Solis M, Stephan R, Bressollette-Bodin C, Salmona M, L'Honneur AS, Behillil S, Lefeuvre C, Dina J, Hantz S, Hartard C, Veyer D, Delagrèverie HM, Fourati S, Visseaux B, Henquell C, Lina B, Foulongne V, Burrel S; SFM COVID-19 study group. Alizon S, et al. Among authors: dina j. Euro Surveill. 2022 Feb;27(6):2100406. doi: 10.2807/1560-7917.ES.2022.27.6.2100406. Euro Surveill. 2022. PMID: 35144725 Free PMC article.
What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020.
Prévot-Monsacré P, Hamaide-Defrocourt F, Guyonvarch O, Masse S, Souty C, Mamou T, Hamel J, Antona D, Mathieu P, Vasseur P, Lévy-Bruhl D, Baroux N, Rossignol L, Vaillant L, Guerrisi C, Hanslik T, Dina J, Blanchon T. Prévot-Monsacré P, et al. Among authors: dina j. Vaccine. 2024 Feb 15;42(5):1065-1070. doi: 10.1016/j.vaccine.2023.12.017. Epub 2023 Dec 12. Vaccine. 2024. PMID: 38092609 Free article.
Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024.
Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM; RELAB Study Group; Laboratory group; Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A; Members of the Laboratory Group; Members of the RELAB Study Group. Traore A, et al. Euro Surveill. 2025 Jan;30(1):2400293. doi: 10.2807/1560-7917.ES.2025.30.1.2400293. Euro Surveill. 2025. PMID: 39790077 Free PMC article.
85 results